Moleculin Biotech is trading at $0.80 (+6.60%), with no clear company-specific catalyst identified for September 9, 2026.
- The latest listed company announcement was August 27, regarding CEO participation in a virtual investor conference; no newer major release appears available.
- Broader U.S. indexes are lower, so the move is not clearly explained by overall market direction.